Hypothalamic-Pituitary-Adrenocortical (HPA) axis response and biotransformation of oral naltrexone: Preliminary examination of relationship to family history of alcoholism

Neuropsychopharmacology

Volumn 26, Issue 6, 2002, Pages 778-788

  King, Andrea C ^a,b   Schluger, James ^b   Gunduz, Mithat ^b   Borg, Lisa ^b   Perret, Guillaume ^b   Ho, Ann ^b   Kreek, Mary Jeanne ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

6 naltrexol; ACTH; Cortisol; HPA axis; Naltrexone; Opioid antagonist

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; NALTREXONE; OPIATE RECEPTOR; PLACEBO;

ADULT; ALCOHOLISM; ARTICLE; BIOTRANSFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DRUG EFFECT; FAMILY HISTORY; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MOOD; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADRENOCORTICOTROPIC HORMONE; ADULT; ALCOHOLISM; ANALYSIS OF VARIANCE; BIOTRANSFORMATION; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; PITUITARY-ADRENAL SYSTEM;

EID: 0036234623     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(01)00416-X     Document Type: Article

References (66)

1. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: Results of a placebo-controlled trial
2. Development and initial validation of a measure of drinking urges in abstinent alcoholics
3. Single nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: Possible implications for opiate addiction
4. High-dose naloxone infusion in normals
5. Effect of naloxone on the hormone response to CRF in normal man
6. The urinary excretion profiles of naltrexone in man
7. Some endocrinologic observations in narcotic addicts
8. Naltrexone increases the latency to drink alcohol in social drinkers
9. Opioid peptide and α-adrenoceptor pathways in the regulation of the pituitary-adrenal axis in man
10. Detecting alcoholism: The CAGE questionnaire
11. Variable dose naltrexone-induced hypothalamic-pituitary-adrenal stimulation in abstinent alcoholics: A preliminary study
12. Narcotic antagonistic activity of several metabolites of naloxone and naltrexone testing in morphine dependent mice
13. Different pituitary β-endorphin and adrenal cortisol response to ethanol in individuals with high and low risk for future development of alcoholism
14. Enhanced sensitivity of pituitary β-endorphin to ethanol in subjects at high risk of alcoholism
15. Naltrexone: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence
16. The Fagerström Test for nicotine dependence: A revision of the Fagerström tolerance questionnaire
17. Mechanisms of stress: A dynamic overview of hormonal and behavioral homeostasis
18. Acute neuroendocrine effects of oral naltrexone in family history positive and negative social drinkers
19. Naltrexone biotransformation and incidence of subjective side effects: A preliminary study
20. Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence
21. Stress, corticotropin-releasing factor, and drug addiction
22. Cortisol levels during chronic naltrexone maintenance treatment in ex-opiate addicts
23. A preliminary study of beta-endorphin during chronic naltrexone maintenance treatment in ex-opiate addicts
24. Naltrexone vs. nefazodone for treatment of alcohol dependence: A placebo-controlled study
25. Medical safety, side effects, and toxicity of methadone
26. Physiological implications of methadone treatment
27. Medical complications in methadone patients
28. Rationale for maintenance pharmacotherapy of opiate dependence
29. Opiates, opioids, SNPs and the addictions: Nathan B. Eddy Memorial Award for lifetime excellence in drug abuse research lecture
30. ACTH, cortisol, and beta-endorphin response to metyrapone testing during chronic methadone maintenance treatment in humans
31. Detection of single nucleotide polymorphisms of the human mu opioid receptor gene by hybridization or single nucleotide extension on custom oligonucleotide gelpad microchips: Potential in studies of addiction
32. Greater reinforcement from alcohol for those at risk: Parental risk, personality risk, and gender
33. Endogenous opioid activity is associated with obsessive-compulsive symptomology in individuals with a family history of alcoholism
34. Effects of naloxone on diurnal rhythms in mood and endocrine function: A dose-response study in man
35. Serum 6-beta-naltrexol levels are related to alcohol responses in heavy drinkers
36. Effects of naltrexone on mood and neuroendocrine function in normal adult males
37. Endocrine effects of naloxone-induced opiate receptor blockade
38. Naloxone effects on b-endorphin, cortisol, prolactin, growth hormone, HVA, MHPG, in plasma of normal volunteers
39. Naltrexone decreases craving and alcohol self-administration in alcohol dependent subjects and activates the hypothalamo-pituitary-adrenocorticol axis
40. Validity of young adults' reports of parental drinking practices
41. Naltexone and coping skills therapy for alcohol dependence: A controlled study
42. Ethanol-induced change in cardiac and endogenous opiate function and risk for alcoholism
43. The brief MAST: A shortened version of the Michigan alcoholism screening test
44. A shortened version of the profile of mood states
45. Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: Implications for the treatment of alcoholism
46. A simultaneous evaluation of multiple markers of ethanol/placebo challenges in sons of alcoholics and controls
47. Plasma cortisol levels following ethanol in sons of alcoholics and controls
48. Alcohol consumption, ACTH level, and family history of alcoholism
49. Alcohol challenges in young men from alcoholic pedigrees and control families: A report from the COGA project
50. Reports of paternal alcoholism: Reliability across siblings
51. Naltrexone-induced alterations in human ethanol intoxication
52. Naltrexone: Disposition, metabolism, and effects after acute and chronic dosing
53. Naloxone increases ACTH and cortisol levels in man
54. Hormonal and other effects of naltrexone in normal men
55. Naltrexone in the treatment of alcohol dependence
56. Naltrexone and alcohol dependence: Role of subject compliance
57. Metabolism and disposition of naltrexone in man after oral and intravenous administration
58. Family history of alcoholism and hypothalamic opioidergic activity
59. Adrenocorticotropin responses to naloxone in sons of alcohol-dependent men
60. Adrenocortical responses and family history of alcoholism
61. Confirmation that offspring from families with alcohol-dependent individuals have greater hypothalamic-pituitary-adrenal axis activation induced by naloxone compared with offspring without a family history of alcohol dependence
62. Adrenocorticotropin responses following administration of ethanol and ovine corticotropin-releasing hormone in the sons of alcoholics and controls subjects